Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Marfan Syndrome | 4 | 2018 | 142 | 0.540 |
Why?
|
| Atenolol | 4 | 2018 | 42 | 0.500 |
Why?
|
| Losartan | 4 | 2018 | 46 | 0.490 |
Why?
|
| Aortic Diseases | 2 | 2018 | 206 | 0.270 |
Why?
|
| Aorta | 3 | 2018 | 692 | 0.240 |
Why?
|
| Specialization | 1 | 2003 | 130 | 0.210 |
Why?
|
| Catheterization | 2 | 2016 | 410 | 0.200 |
Why?
|
| Medicine | 1 | 2003 | 137 | 0.200 |
Why?
|
| Thrombosis | 2 | 2018 | 781 | 0.190 |
Why?
|
| Adenoviridae | 2 | 2016 | 1459 | 0.170 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 395 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 573 | 0.160 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2018 | 68 | 0.160 |
Why?
|
| Vascular Stiffness | 1 | 2018 | 77 | 0.150 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2016 | 14 | 0.140 |
Why?
|
| Blood Vessels | 1 | 2017 | 217 | 0.140 |
Why?
|
| alpha-Glucosidases | 1 | 2016 | 55 | 0.140 |
Why?
|
| Asthma | 1 | 2003 | 871 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 263 | 0.130 |
Why?
|
| Thrombectomy | 1 | 2016 | 158 | 0.130 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2016 | 160 | 0.130 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 34 | 0.120 |
Why?
|
| Stents | 2 | 2017 | 1096 | 0.120 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2014 | 88 | 0.110 |
Why?
|
| Pulmonary Valve | 1 | 2014 | 87 | 0.110 |
Why?
|
| Hemophilia B | 1 | 2012 | 14 | 0.110 |
Why?
|
| Factor IX | 1 | 2012 | 30 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 323 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 384 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 655 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2014 | 230 | 0.100 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 124 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 998 | 0.100 |
Why?
|
| Genetic Vectors | 2 | 2016 | 1694 | 0.100 |
Why?
|
| Genetic Therapy | 2 | 2016 | 1616 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 516 | 0.100 |
Why?
|
| Heart Defects, Congenital | 3 | 2017 | 1697 | 0.090 |
Why?
|
| Macaca mulatta | 1 | 2012 | 717 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 386 | 0.090 |
Why?
|
| Liver | 2 | 2016 | 2961 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1171 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 563 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2012 | 846 | 0.080 |
Why?
|
| Child, Preschool | 6 | 2018 | 16273 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2018 | 749 | 0.060 |
Why?
|
| Adolescent | 7 | 2018 | 31252 | 0.060 |
Why?
|
| Helper Viruses | 2 | 2016 | 55 | 0.060 |
Why?
|
| Quality of Life | 1 | 2018 | 4532 | 0.060 |
Why?
|
| Heart Failure | 1 | 2018 | 2516 | 0.060 |
Why?
|
| Nasal Polyps | 1 | 2003 | 27 | 0.060 |
Why?
|
| Child | 7 | 2018 | 29154 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 1085 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1237 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 285 | 0.050 |
Why?
|
| Sinusitis | 1 | 2003 | 131 | 0.050 |
Why?
|
| Palliative Care | 1 | 2012 | 2037 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2003 | 216 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2003 | 289 | 0.050 |
Why?
|
| Infant | 4 | 2018 | 13310 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 334 | 0.050 |
Why?
|
| Male | 10 | 2018 | 123000 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2003 | 629 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2003 | 636 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2017 | 8223 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 1819 | 0.040 |
Why?
|
| Dilatation | 1 | 2018 | 83 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2018 | 46 | 0.040 |
Why?
|
| Female | 9 | 2018 | 141928 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 4320 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2018 | 224 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2018 | 32848 | 0.040 |
Why?
|
| Papio | 1 | 2016 | 70 | 0.040 |
Why?
|
| Length of Stay | 2 | 2014 | 1900 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 310 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 76 | 0.030 |
Why?
|
| Vascular Access Devices | 1 | 2016 | 51 | 0.030 |
Why?
|
| Angioplasty | 1 | 2016 | 94 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 6869 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2016 | 218 | 0.030 |
Why?
|
| Diaphragm | 1 | 2016 | 181 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 1183 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 17523 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 452 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 21445 | 0.030 |
Why?
|
| Humans | 10 | 2018 | 261506 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 6942 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 799 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2014 | 167 | 0.030 |
Why?
|
| Adult | 4 | 2018 | 77950 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12221 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 1182 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2017 | 37905 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2018 | 899 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2018 | 787 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 1204 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 3472 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2012 | 475 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 557 | 0.020 |
Why?
|
| Myocardium | 1 | 2016 | 1313 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 4938 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 4988 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 1270 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6207 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5637 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 4758 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 5377 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 2884 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 34495 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10001 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 12926 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 4053 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 21713 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 59536 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 7222 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 14889 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 86204 | 0.010 |
Why?
|